• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archives for January–April 2018

Anemia During Pregnancy Increases the Risk of RBC Transfusions After Delivery for New Moms

Fifteen to thirty percent of pregnant women are diagnosed with anemia (hemoglobin [Hb] less than 11.0 g/dL) and are at…

February 14, 2018

High-Throughput Exome Sequencing Clarifies Serology Typing and Helps Identify Rare and Novel Blood Group Alleles

 Next Generation Sequencing (NGS), also known as high-throughput sequencing and massively parallel sequencing, is a revolutionary sequencing technique that amplifies…

February 7, 2018

Alloimmunization to One RBC Antigen Triggers Alloimmunization to Other RBC Antigens

The risk of alloimmunization to polymorphic RBC antigens is high for individuals who undergo chronic transfusion therapy.  Researchers recently utilized…

January 31, 2018

Global Variations in Blood Safety and Availability Based on WHO Report

Every two years since 1998 the World Health Organization (WHO) has collected data on blood safety and availability. The WHO…

January 24, 2018

Cell Salvage for Cesarean Sections

Cell savage, the collection and return of lost autologous blood during surgery, is frequently used in cardiothoracic and vascular surgeries….

January 17, 2018

RBC Transfusions for Palliative Care Patients

Palliative care is a proactive and personalized approach for improving physical and spiritual problems in terminally ill patients. Cancer patients…

January 9, 2018

Successful Treatment of Refractory B-cell Lymphomas with CAR T-Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapy has been shown to successfully treat refractory B-cell lymphomas. Two new studies published in…

January 3, 2018

  • « Previous Page
  • Page 1
  • Page 2

Primary Sidebar

Latest News

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley